SVP Clinical Development Jeffrey Wiezorek sold $77K of Kite Pharma, Inc.

Sold$76,820

$51.21Price

1,500Shares

−7%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Wed, Feb 1. Filed Mon, Feb 6, 11:36 AM ET, during the session. Not investment advice.